Veracyte, Inc.

VCYT21 Jan 2025
Healthcare
$41.8
+0.05 (+4.95%)
Lowest Today
$41.79
Highest Today
$42.41
Today’s Open
$41.8
Prev. Close
$40.58
52 Week High
$46
52 Week Low
$18.61
To Invest in Veracyte, Inc.

Veracyte, Inc.

Healthcare
VCYT21 Jan 2025
+0.05 (+4.95%)
1M
3M
6M
1Y
5Y
Low
$41.79
Day’s Range
High
$42.41
41.79
52 Week Low
$18.61
52-Week Range
52 Week High
$46
18.61
1 Day
-
1 Week
-5.21%
1 month return
+3.73%
3 month return
+22.42%
6 month return
+75.24%
1 Year return
+58.97%
3 Years return
+49.09%
5 Years return
+43.05%
10 Years return
-
Institutional Holdings
Vanguard Group Inc
10
BlackRock Inc
9.85
Artisan Partners Limited Partnership
6.48
ARK Investment Management LLC
6.35
Wellington Management Company LLP
5.46
Dimensional Fund Advisors, Inc.
3.91
ArrowMark Colorado Holdings, LLC (ArrowMark Partners)
3.85

Market Status

Fundamentals
Market Cap
3144.93 mln
PB Ratio
2.71
PE Ratio
0
Enterprise Value
2930.85 mln
Total Assets
1114.91 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; Percepta Nasal Swab Test for lung cancer diagnosis; and Envisia Genomic Classifier for diagnosing interstitial lung disease, including idiopathic pulmonary fibrosis. It is also developing Envisia Classifier, the nCounter analysis system; and LymphMark for lymphoma subtyping test. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Organisation
Veracyte, Inc.
Employees
815
Industry
Diagnostics & Research
CEO
Mr. Marc A. Stapley
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step